Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Pharma Guide

To find a commercial service, choose an option from the Main Category below or Search by Company Name.

Pipeline Monitor
FDA shoots down Olumiant
The FDA has surprised by rejecting Lilly and Incyte's oral rheumatoid arthritis drug Olumiant, diverging from the EU's approval of the drug in February.
Approvals Action
Keytruda wins another indication
The TGA has revealed the granting of a new indication to MSD's blockbuster cancer drug Keytruda and CSL's new product Afstyla has been approved for treating haemophilia A.
Debating Point
What couldn't we do if we tried?
Industry incubator MTP Connect and the CSIRO may have laid out an ambitious industry roadmap but it doesn't disguise the effort that will be needed from all stakeholders if the destination is to be reached.